Associations of reproductive factors and exogenous estrogens with global and domain-specific cognition in later life

Alzheimers Dement. 2024 Jan;20(1):63-73. doi: 10.1002/alz.13394. Epub 2023 Jul 14.

Abstract

Introduction: Few studies have comprehensively examined the impact of reproductive factors (i.e., reproductive window, parity, hormonal contraception [HC], and menopausal hormone therapy [MHT]) on global and domain-specific cognition in later life.

Methods: We studied a population-based sample of 2458 women (median age 74.2 years) residing in Olmsted County, Minnesota; participants underwent a clinical evaluation and comprehensive cognitive testing.

Results: The length of a woman's reproductive window was not associated with cognition. Higher parity was associated with greater cognitive decline in all domains. Ever HC use was associated with less decline in all domains. Ever MHT use was associated with greater decline in global cognition and all domain-specific z-scores except visuospatial; results were driven by women who initiated MHT 5 or more years after menopause. Additional adjustments for APOE and vascular-related covariates did not attenuate the results.

Discussion: Multiple reproductive risk factors are associated with cognitive decline in later life.

Highlights: The length of a woman's reproductive window was not associated with cognition longitudinally. Greater parity was associated with greater cognitive decline longitudinally. Ever HC use was associated with less decline in global cognition and all domain-specific z-scores longitudinally (all p < 0.01). Ever MHT use was associated with greater decline in global cognition and all domain-specific z-scores except visuospatial longitudinally (all p < 0.01). The greatest cognitive decline was among women who initiated MHT more than 5 years after menopause.

Keywords: cognition; epidemiology; hormonal contraception; menarche; menopausal hormone therapy; menopause; pregnancy.

MeSH terms

  • Aged
  • Cognition
  • Cognitive Dysfunction*
  • Estrogens* / adverse effects
  • Female
  • Humans
  • Menopause
  • Risk Factors

Substances

  • Estrogens